Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
Date:11/13/2008

sets 968 -

Changes in:

Accounts receivable 111 (1,029)

Inventories 269 988

Prepaid expenses and other current assets 472 483

Deposits other than on property and

equipment, and other assets (250) 250

Accounts payable 931 706

Accrued expenses (657) (1,975)

Deferred product revenue - (189)

Net cash used in operating activities (15,043) (28,662)

Cash flows from investing activities:

Repurchase of Keflex assets from Deerfield (12,190) -

Purchases of marketable securities (11,240) (5,868)

Sale and maturities of marketable securities 2,380 5,530

Purchases of property and equipment (39) (246)

Deposits on property and equipment - (1,150)

Proceeds from sale of fixed assets 472 -

Net cash used in investing activities (20,617) (1,734)

Cash flows from financing activities:

Proceeds from private placement of common

stock, net of issue costs 115,943 22,412

Payments on lines of credit - (2,000)

Proceeds from exercise of common stock

options 758 115

Proceeds from exercise of common stock

warrants 164 -

Payment to settle warrant liability (8,814) -

Net cash provided by financing

activities
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
5. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
6. MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
7. MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
10. MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
(Date:12/26/2014)... said that nothing makes a lady feel more feminine than ... shows its new selection of navy cocktail dresses , ... navy cocktail gowns are the cornerstones of the site’s cocktail ... dresses in bright neon colors can be dressed up or ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... 11, 2007 Physicians at UT Southwestern Medical Center are the ... small radioactive pellet, or seed, is implanted into a mass or ... surgical removal. , During the procedure, a radiologist uses a needle ... grain of rice, into the mass. Once lodged, surgeons use a ...
... Oct. 11, 2007 Dr. Beth Levine, professor ... division of infectious diseases at UT Southwestern Medical Center, ... today. , Dr. Levine is one of 15 new ... a philanthropic organization that promotes biomedical research. Her appointment ...
... 1999 Equity ... Incentive Plan, ... leading provider of state-of-the-art diagnostic and,digital imaging systems directed towards women,s ... that,Hologic stockholders vote "FOR" the Company,s proposed merger with Cytyc,Corporation (Nasdaq: ...
... Just released trial data show high acceptance of interactive ... system, two-thirds of patients prefer automated system, ... a developer,of advanced interactive voice response (IVR) solutions, today ... (IVRS) optimized,for use in the healthcare environment. CallAssure uses ...
... Step-by-Step Process and Provides Sample Appeal,Letter, WASHINGTON, Oct. ... peace of mind that they will have,access to the ... the medicine that,s prescribed by the doctor isn,t always,covered. ... need,to know what they can do about it., ...
... Quality of Health Care, PITTSBURGH, Oct. 11 ... select hospitals in Western Pennsylvania as part of ... line- associated bloodstream infections. Central lines are ... nutrition to critically ill patients through vessels that ...
Cached Medicine News:Health News:New 'seed' therapy helps pinpoint breast tumors with more accuracy 2Health News:UT Southwestern researcher named Howard Hughes Medical Institute investigator 2Health News:UT Southwestern researcher named Howard Hughes Medical Institute investigator 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 4Health News:Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up 2Health News:Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up 3Health News:New Resource Explains What Seniors Can Do if Medicare Denies Coverage of Their Medicines 2Health News:Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results 2Health News:Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results 3
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft ... Company,s Phase 2 clinical trial.  This open-label study will ... GPX-150 (an investigational medication), in approximately 30 adults as ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 ...
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
The VISERA Multi-Specialty Digital Imaging Platform is the world's first integrated system of digital rigid, deflectable tip and flexible videoscopes for use in operating room endosurgery as well as ...
... for clinical image management. Mediscan is ... management system derived from extensive experience ... to capture, organize, and distribute high ... with minimum effort. Can be connected ...
... probes feature response times in ... real-time monitoring of physiological events. ... measurements of pO2, blood perfusion ... from the same tissue site ...
Medicine Products: